How much funding has NEOVAXSYN INC raised?

NEOVAXSYN INC has raised $300K in total funding, most recently a Grant round.

When was NEOVAXSYN INC founded?

NEOVAXSYN INC was founded in 2020.

Where is NEOVAXSYN INC headquartered?

NEOVAXSYN INC is headquartered in AMES, Iowa, United States.

What industry is NEOVAXSYN INC in?

NEOVAXSYN INC operates in Biotech, Healthcare.

How many employees does NEOVAXSYN INC have?

NEOVAXSYN INC has 1-10 employees.

NEOVAXSYN INC

Q: Who are NEOVAXSYN INC's investors?

NEOVAXSYN INC's investors include National Institute of Allergy and Infectious Diseases.

AMES, United States · Founded 2020 · $300K raised

Biotech

Healthcare

Headquarters: AMES, Iowa
Employees: 1–10
Founded: 2020
Business Model: B2G

Total Funding: $300K
Last Round: $300K GrantJan 2023
Rounds: 1

About

NeoVaxSyn, Inc. is a Salt Lake City-based vaccine R&D company developing novel immunogens designed to induce broadly protective neutralizing antibodies against viruses including HIV-1, influenza, and SARS-CoV-2. The company focuses on engineering vaccine candidates that target critical epitopes on viral surface antigens to enable stronger immune responses. Funded through NIH SBIR/STTR awards from the Department of Health and Human Services.

Summary

NEOVAXSYN INC is a Biotech company based in AMES, United States, founded in 2020. It has raised $300K in total across 1 round, most recently a $300K Grant round in Jan 2023. Investors include National Institute of Allergy and Infectious Diseases.